Amy Tiersten Selected Research

Amy Tiersten Research Topics

Disease

21	Breast Neoplasms (Breast Cancer) 12/2024 - 10/2003
13	Neoplasms (Cancer) 12/2024 - 09/2010
4	Ovarian Neoplasms (Ovarian Cancer) 08/2023 - 11/2013
3	Neutropenia 08/2023 - 10/2003
3	Triple Negative Breast Neoplasms 01/2020 - 03/2014
2	Neoplasm Metastasis (Metastasis) 10/2014 - 12/2012
1	Dermatitis 12/2024
1	Residual Neoplasm 01/2024
1	Pathologic Complete Response 01/2024
1	Fatigue 08/2023
1	Disease Progression 08/2023
1	Anemia 08/2023
1	Vascular Remodeling 08/2023
1	Nausea 08/2023
1	Hyperglycemia 08/2023
1	Hepatitis 08/2023
1	Insulin Resistance 10/2021
1	Lymphadenopathy 01/2016
1	Thrombocytopenia (Thrombopenia) 03/2014
1	Ovarian Epithelial Carcinoma 09/2010
1	Heart Failure 08/2004
1	Hypertension (High Blood Pressure) 08/2004
1	Cardiotoxicity 08/2004
1	Diabetes Mellitus 08/2004

Drug/Important Bio-Agent (IBA)

9	Hormones (Hormone)IBA 12/2023 - 01/2020
3	Tamoxifen FDA LinkGeneric 01/2020 - 07/2004
3	Carboplatin (JM8)FDA LinkGeneric 01/2016 - 08/2004
2	ruxolitinibIBA 12/2024 - 08/2021
2	Immune Checkpoint InhibitorsIBA 12/2024 - 08/2023
2	Fulvestrant (Faslodex)FDA Link 01/2024 - 01/2023
2	AntigensIBA 08/2023 - 03/2014
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 10/2022
2	taxaneIBA 01/2016 - 11/2013
2	AnthracyclinesIBA 01/2016 - 08/2004
2	Imiquimod (Aldara)FDA LinkGeneric 10/2014 - 12/2012
2	PlatinumIBA 03/2014 - 11/2013
2	Topotecan (Hycamtin)FDA LinkGeneric 03/2014 - 11/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2010 - 08/2004
1	Janus Kinase InhibitorsIBA 12/2024
1	pembrolizumabIBA 12/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	Estrogen ReceptorsIBA 01/2024
1	Anastrozole (Arimidex)FDA LinkGeneric 01/2024
1	Phenobarbital (Luminal)FDA Link 01/2024
1	Alkaline PhosphataseIBA 08/2023
1	eribulin FDA Link 08/2023
1	durvalumabIBA 08/2023
1	Estrogens (Estrogen)FDA Link 04/2023
1	ribociclibIBA 01/2023
1	exemestane (Aromasin)FDA Link 01/2023
1	Cyclin-Dependent Kinase 4IBA 01/2023
1	Aromatase InhibitorsIBA 04/2022
1	hydroxide ionIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 10/2021
1	Insulin (Novolin)FDA Link 10/2021
1	Trastuzumab (Herceptin)FDA Link 08/2021
1	veliparibIBA 01/2020
1	Metformin (Glucophage)FDA LinkGeneric 01/2020
1	1-dodecylpyridoxal (PLD)IBA 01/2020
1	liposomal doxorubicin (Doxil)FDA Link 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Topoisomerase InhibitorsIBA 02/2017
1	Bevacizumab (Avastin)FDA Link 02/2017
1	Irinotecan (Camptosar)FDA LinkGeneric 02/2017
1	Antidepressive Agents (Antidepressants)IBA 02/2016
1	Everolimus FDA Link 03/2014
1	Sirolimus (Rapamycin)FDA Link 03/2014
1	TOR Serine-Threonine KinasesIBA 03/2014
1	CollagenIBA 03/2014
1	EpitopesIBA 03/2014
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2014
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 11/2013
1	Toll-Like Receptor 7IBA 12/2012
1	CytokinesIBA 12/2012
1	Imatinib Mesylate (Gleevec)FDA Link 09/2010
1	Melphalan (Alkeran)FDA LinkGeneric 08/2004
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2004
1	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 08/2004

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 08/2023 - 10/2003
5	Therapeutics 12/2024 - 08/2021
2	Neoadjuvant Therapy 01/2024 - 01/2016
1	Adjuvant Chemotherapy 10/2022
1	Duration of Therapy 10/2003
1	Treatment Delay 10/2003